Expert Opinion on Drug Metabolism & Toxicology, Volume 9, Issue 6 (2013)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Metabolism & Toxicology, Volume 9, Issue 6 (2013)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Volume 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Reviews

Review Article
Metabolic and toxicological considerations for obsessive–compulsive disorder drug therapy
Mohammad Sayyah PharmD PhD, Sayeh Majzoob PharmD PhD & Mehdi Sayyah MD
Pages: 657-673
Published online: 25 Mar 2013
AbstractforMetabolic and toxicological considerations for obsessive–compulsive disorder drug therapy | Full Text | References | PDF (312.3 KB)
  • 302 Views
  • 2 CrossRef citations
  • 0Altmetric
Review Article
Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine
David E Moody (Associate Director Center for Human Toxicology, Research Professor) PhD
Pages: 675-697
Published online: 29 Mar 2013
AbstractforMetabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine | Full Text | References | PDF (669.7 KB)
  • 725 Views
  • 17 CrossRef citations
  • 0Altmetric
Review Article
Alternative methods for ocular toxicology testing: validation, applications and troubleshooting
Sanjay L Dholakiya & Frank A Barile (Professor of Clinical And Applied Toxicology) PhD
Pages: 699-712
Published online: 26 Mar 2013
AbstractforAlternative methods for ocular toxicology testing: validation, applications and troubleshooting | Full Text | References | PDF (354.5 KB)
  • 397 Views
  • 14 CrossRef citations
  • 0Altmetric
Review Article
Role of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease
Igor P Pogribny MD PhD & Frederick A Beland
Pages: 713-724
Published online: 09 Apr 2013
AbstractforRole of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease | Full Text | References | PDF (482.6 KB)
  • 431 Views
  • 9 CrossRef citations
  • 0Altmetric
Review Article
Utilization of glutathione S-transferase Mu 1- and Theta 1-null mice as animal models for absorption, distribution, metabolism, excretion and toxicity studies
Shingo Arakawa
Pages: 725-736
Published online: 18 Mar 2013
AbstractforUtilization of glutathione S-transferase Mu 1- and Theta 1-null mice as animal models for absorption, distribution, metabolism, excretion and toxicity studies | Full Text | References | PDF (375.4 KB)
  • 231 Views
  • 11 CrossRef citations
  • 0Altmetric
Review Article
Optimizing the in vitro and clinical assessment of drug interaction risk by understanding co-medications in patient populations
Jackie Bloomer, Geo Derimanov, Etienne Dumont, Harma Ellens & Christopher Matheny
Pages: 737-751
Published online: 16 Apr 2013
AbstractforOptimizing the in vitro and clinical assessment of drug interaction risk by understanding co-medications in patient populations | Full Text | References | PDF (3.3 MB)
  • 724 Views
  • 12 CrossRef citations
  • 0Altmetric

Drug Evaluations

A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis
Bernard Bannwarth, Marie Kostine & Nicolas Poursac
Pages: 753-761
Published online: 09 Apr 2013
AbstractforA pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis | Full Text | References | PDF (333.3 KB)
  • 1333 Views
  • 27 CrossRef citations
  • 0Altmetric
Canagliflozin, an inhibitor of sodium–glucose cotransporter 2, for the treatment of type 2 diabetes mellitus
Elizabeth M Lamos MD, Lisa M Younk BS & Stephen N Davis (Theodore E. Woodward Professor of Medicine, Chairman, Physician-in-Chief) MBBS FRCP FACP
Pages: 763-775
Published online: 17 Apr 2013
Abstractfor Canagliflozin, an inhibitor of sodium–glucose cotransporter 2, for the treatment of type 2 diabetes mellitus | Full Text | References | PDF (401.9 KB)
  • 1052 Views
  • 43 CrossRef citations
  • 0Altmetric
Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors
Savita Bisht, Georg Feldmann & Peter Brossart
Pages: 777-788
Published online: 16 Apr 2013
AbstractforPharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors | Full Text | References | PDF (436.7 KB)
  • 383 Views
  • 6 CrossRef citations
  • 0Altmetric
Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia
Philippe RS Lagacé-Wiens MD & Ethan Rubinstein MD LLB
Pages: 789-799
Published online: 17 Apr 2013
AbstractforPharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia | Full Text | References | PDF (410 KB)
  • 383 Views
  • 8 CrossRef citations
  • 0Altmetric

Research Article

Article
Related articles
Page: i
Published online: 14 May 2013
CitationforRelated articles | Full Text | PDF (131 KB)
  • 55 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Genetic polymorphisms of drug-metabolizing enzymes in older and newer anti-seizure medications
Gianluca D’Onofrio et al.
Editorial | Published online: 31 May 2024
Free Access
Understanding the impact of ABCG2 Polymorphisms on Drug Pharmacokinetics:Focus on rosuvastatin and allopurinol
Anne Kasten et al.
Review Article | Published online: 29 May 2024
Recent progress in machine learning approaches for predicting carcinogenicity in drug development
Nguyen Quoc Khanh Le et al.
Review Article | Published online: 27 May 2024
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact
Lorenzo Gasperoni et al.
Review Article | Published online: 22 May 2024
Open Access
View all latest articles